D-0083-2019 Class II Terminated
FDA drug recall D-0083-2019 was initiated by Lannett Company, Inc. on Oct 11, 2018 and is designated Class II. Reason for recall: CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities. The recall status is terminated (terminated Feb 22, 2019). Affected quantity: 8,324 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 31, 2018
- Initiation Date
- Oct 11, 2018
- Termination Date
- Feb 22, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,324 bottles
Product description
HydrOXYzine HYDROCHLORIDE SYRUP (HydrOXYzine Hydrochloride Oral Solution, USP), 10 mg per 5 mL, Rx only, Distributed by Lannett Company, Inc., Philadelphia, PA 19154, NDC 54838-502-80.
Reason for recall
CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.
Distribution pattern
Nationwide in the USA
Code information
Lot #: 1097, Exp 10/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0083-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026